Live Breaking News & Updates on Cansino bio

Stay informed with the latest breaking news from Cansino bio on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Cansino bio and stay connected to the pulse of your community

Law 17/2023: Indonesia is taking active steps to improve its healthcare system

Indonesia's new omnibus health law opens up new avenues to enhance its healthcare system, including stronger collaboration with China in vaccine development and genomics research.

Beijing , China , Indonesia , Chengdu , Sichuan , Chinese , Indonesian , Kalbe-farma , Cansino-bio , Budi-gunadi-sadikin , Kimia-farma , Embassy-of-the-republic-indonesia

Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held

HONG KONG, July 31, 2023 - (ACN Newswire) - On 27 July 2023, on the eve of the highly anticipated Chengdu FISU World University Games, the Minister of Health Indonesia Budi Gunadi Sadikin accompanied Indonesian President Joko Widodo

Perwira , Sumatera-utara , Indonesia , China , Shanghai , Shenzhen , Guangdong , Seoul , Soult-ukpyolsi , South-korea , Hong-kong , Beijing

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Perwira , Sumatera-utara , Indonesia , China , Shanghai , Hong-kong , Seoul , Soult-ukpyolsi , South-korea , Beijing , Shenzhen , Guangdong

Exploring New Collaborative Opportunities! The Indonesia-China Healthcare And Biotech Investment Forum Successfully Held

HONG KONG, July 31, 2023 - (ACN Newswire) - On 27 July 2023, on the eve of the highly anticipated Chengdu FISU World University Games, the Minister of Health Indonesia Budi Gunadi Sadikin accompanied Indonesian President Joko Widodo on a visit to China. ...

Shenzhen , Guangdong , China , Seoul , Soult-ukpyolsi , South-korea , Hong-kong , Shanghai , Chengdu , Sichuan , Indonesia , Beijing

Community Scoop » Exploring New Collaborative Opportunities! The Indonesia-China Healthcare And Biotech Investment Forum Successfully Held

Scoop Community provides New Zealand Community news and views

Hong-kong , Beijing , China , Shenzhen , Guangdong , Seoul , Soult-ukpyolsi , South-korea , Chengdu , Sichuan , Indonesia , Shanghai

Cureus | Reactogenicity of COVID-19 Vaccines in Patients With a History of COVID-19 Infection: A Survey Conducted in Pakistan

Introduction

As coronavirus disease 2019 (COVID-19) immunizations become more common, concerns about their safety and reactogenicity have grown. It is important to assess and analyze the post-vaccination side effects of several COVID-19 vaccines that have been licensed in Pakistan.

Methods and results

A comparative cross-sectional study was conducted between October 2021 and January 2022 to collect data on the side effects produced by different COVID-19 vaccines. An online survey was conducted to gather data on participants' demographics, clinical profiles, COVID-19 profiles as well as the intensity and side effects of COVID-19 vaccines. Statistical Package for the Social Sciences (SPSS) version 22.0 (IBM Corp., Armonk, NY) was used to analyze the data collected. Out of 421 participants, 63.2% were males, 36.8% of participants received messenger RNA (mRNA) vaccine, 33.2% received viral vector vaccine, 29.9% received inactivated vaccine, and further 71.7% of the total subjects were completely immunized. The majority of the symptoms were mild to moderate in degree. Approximately, 0.7% of the individuals reported experiencing serious adverse effects. Injection site pain (35.9%) was noted to be the most remarkable post-vaccination side effect followed by fever (33.2%) and fatigue (23.1%). Prior COVID-19 infection was not associated with the severity of any COVID-19 vaccine-related side effect (p > 0.05), except dyspnea. Younger participants and the female gender were substantially linked to post-vaccination adverse effects.

Conclusion

In comparison to viral vector and inactivated vaccines, our data suggest that the mRNA-based vaccination causes more severe adverse effects, and the majority of them were mild to moderate in severity. Participants who had previously contracted COVID-19 were not at a higher risk of developing additional vaccine-related side effects.

Israel , United-states , United-kingdom , Islamabad , Pakistan , Saudi-arabia , South-africa , Gilgit-baltistan , Northern-areas , Israeli , Pakistani , Astrazeneca-oxford

Ocugen, Inc. (OCGN) Q2 2022 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2022.

Mexico , United-states , India , Canada , Philadelphia , Pennsylvania , Washington , America , Bharat , Canadian , American , Jennifer-kim-cantor-fitzgerald

China Has Spent Over $18.8 Billion on COVID-19 Vaccines

The National Healthcare Security Administration of the Chinese Communist Party recently announced that the total cost of China's ...

Beijing , China , Chinese , Zhifei-bio , Sino-biopharm , Mao-huihua , Jessica-mao , Kangtai-bio , Cansino-bio , Zhu-tao , Qiu-dongxu , Cansino-biologics

One-dose Human Papillomavirus vaccine offers solid protection against cervical cancer

One-dose Human Papillomavirus vaccine offers solid protection against cervical cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Nothemba-nono-simelela , Alejandro-cravioto , Strategic-advisory-group-of-experts-on-immunization , Cervical-cancer-elimination-initiative , Advisory-group , Human-papillomavirus , Director-general-dr-princess-nothemba , Cansino-bio , Polio-vaccine , Strategic-advisory-group ,

One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer

GENEVA, Switzerland - The April 4-7, 2022, convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been

Geneva , Genè , Switzerland , Nothemba-nono-simelela , Alejandro-cravioto , Strategic-advisory-group-of-experts-on-immunization , Cervical-cancer-elimination-initiative , Advisory-group , Human-papillomavirus , Cansino-bio , Polio-vaccine , Strategic-advisory-group